Answers are grounded in this paper and cite their sources.
Experts discuss AI's potential in diabetes care, pointing to personalized approaches and public health implications.
Diabetes has become a major public health challenge due to its high prevalence and chronic nature, with many individuals managing the condition for decades. The vast heterogeneity in diabetes necessitates personalized approaches to its prevention, diagnosis, treatment, and prognosis. Recently, the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health convened experts from the fields of diabetes and AI to identify and discuss existing gaps, as well as potentially transformative opportunities and actionable items enabled by recent advancements in AI. One prominent theme that has emerged from this discussion was the considerable potential of AI in Diabetes Precision Health, a field that warrants greater attention. The purpose of this article is to describe the opportunities and challenges identified during the workshop and outline potential strategies recommended by workshop attendees to advance this promising field.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: